Clinical Laserthermia Systems AB Class B (LS60) Stock Statistics & Valuation Metrics

Clinical Laserthermia Systems AB Class B has a market cap or net worth of €9.74M. The enterprise value is €79.44M.

Clinical Laserthermia Systems AB Class B has 31,163,593 shares outstanding. The number of shares has decreased by -2.65% in one year.

Clinical Laserthermia Systems AB Class B’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is -43.61%.

The current PE Ratio of Clinical Laserthermia Systems AB Class B is ―. Clinical Laserthermia Systems AB Class B’s PEG ratio is 0.07.

In the last 12 months, Clinical Laserthermia Systems AB Class B had revenue of 17.49M and earned -41.61M in profits. Earnings per share was -1.61.

In the last 12 months, operating cash flow was -31.20M and capital expenditures -3.58M, giving a free cash flow of -34.79M billion.

Clinical Laserthermia Systems AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―

Clinical Laserthermia Systems AB Class B upcoming earnings date is Aug 14, 2026, TBA (Confirmed).

Clinical Laserthermia Systems AB Class B as a current ratio of 3.91, with Debt / Equity ratio of 0.00%

In the past 12 months, Clinical Laserthermia Systems AB Class B has paid 0.00 in taxes.

Clinical Laserthermia Systems AB Class B EV to EBITDA ratio is -5.92, with an EV/FCF ratio of -4.36.

Clinical Laserthermia Systems AB Class B has €13.04M in cash and marketable securities with €0.00 in debt, giving a net cash position of €13.04M billion.

Gross margin is -15.91%, with operating margin of -165.81%, and net profit margin of -237.96%.

The average price target for Clinical Laserthermia Systems AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―